CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
La Jolla Pharmaceutical (NASDAQ: LJPC) is a biopharmaceutical firm engaged in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.
Company (IPO / Went public)
Phone: 858-207-4264
4550 Towne Centre Court
San Diego, 92121
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| La Jolla Pharmaceutical Company | $196M | Feb 6, 2006 |
| OraPharma | $105.9M | Jun 18, 2012 |
| Bayhill Therapeutics | $97.4M | Jun 11, 2011 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Inhibition of bmp signaling, compounds, compositions and uses thereof | Mar 14, 2019 | Aug 18, 2020 | Patent |
| Glycolipids as treatment for disease | Nov 23, 2015 | Feb 11, 2020 | Patent |
| Methods for administering angiotensin ii | Jan 06, 2017 | Sep 10, 2019 | Patent |
| Mutant endoglycoceramidases with enhanced synthetic activity | Jun 29, 2015 | May 21, 2019 | Patent |
| Compositions and methods for treating renal failure | Apr 28, 2014 | Oct 04, 2016 | Patent |
